PROF
Profound Medical Corp.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 5 ▲ Profound Medical reported strong Q4 and full-year 2025 results with…
- Mar 5 Profound Medical reported record Q4 and full-year 2025 results, with…
- Mar 9 FDA: Profound Medical to Host Investor Call to Discuss First Cl…
- Apr 1 FDA: Incision-Free, MRI-Guided Prostate Treatment with Profound…
- Jul 24 ▲ Profound Medical announced new CAPTAIN trial data showing statistica…
- Oct 7 ▲ Profound Medical announced preliminary Q3 2026 revenue of $9.8M-$10.…
- Oct 30 Contract: Profound Medical and Cook Medical’s iMRI Division Partner…
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q3 2026: 1 added (0 new), 2 trimmed or exited.
- Short sellersSTEADY
Short interest +1.4% to 1.58M shares. 9.8 days to cover, ≈4.3% of shares.
- TrendUPTREND
16% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| RAYMOND JAMES FINANCIAL INC | ADD | $1.6M |
| UBS Group AG | NEAR_EXIT | $43.1K |
| MORGAN STANLEY | TRIM | $24.4K |
| First Eagle Investment Management, LLC | ADD | $2.9M |
| RAYMOND JAMES FINANCIAL INC | ADD | $1.3M |
| UBS Group AG | TRIM | $367.2K |
| MORGAN STANLEY | DOUBLED | $47.0K |
| WELLS FARGO & COMPANY/MN | TRIM | $26.6K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Jan 2026Price is below the lowest target. Median implies +53%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Jan 7, 2026 | Lake Street MAINTAIN | Buy |
| Apr 23, 2025 | Lake Street MAINTAIN | Buy |
| Jul 16, 2024 | Stifel UPGRADE | Buy |
| Mar 11, 2024 | Alliance Global Partners MAINTAIN | Buy |
| Mar 8, 2024 | Stifel MAINTAIN | Hold |
| Jan 4, 2024 | Alliance Global Partners MAINTAIN | Buy |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$0.22 | -$0.24–-$0.18 | -5.7% | $11.9M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
19 filings · 3 press releases · 3 bullish · 1 bearish · 15 neutral- NEUTRAL 8-KNov 12, 2026
Profound Medical Corp. disclosed a leadership transition: CEO Arun Menawat will become Executive…
Monitor the January 15, 2027 transition date for any strategic shifts under new CEO Richard Fabian, who comes from an ultrasound imaging background. The CFO appointment removes interim status…
- NEUTRAL 8-KNov 9, 2026
Profound Medical filed an 8-K announcing its management will present at the Stifel 2026 Healthcare…
Monitor the conference presentation and any one-on-one meeting feedback for potential updates on TULSA-PRO adoption or Sonalleve commercial progress, but this filing itself contains no new…
- BEARISH 8-KNov 5, 2026
Profound Medical reported Q3 2026 revenue of $9.8M (+86% YoY), well below the $13.8M consensus…
The revenue miss versus consensus is the primary negative, though the 86% YoY growth and improving cash burn trajectory are positive. Watch for the RSNA 2026 CAPTAIN data presentation (Nov 29-Dec 3)…
- NEUTRAL 8-KNov 3, 2026
Profound Medical entered into a supply and distribution agreement with Cook Medical's iMRI…
The agreement is contingent on FDA clearance for TULSA-PRO with Cook Equipment, with a deadline of April 30, 2027. Monitor for FDA 510(k) clearance announcements and initial system placements…
All PROF filing & press-release reports (22)
- 8-K reportNov 12, 2026
- 8-K reportNov 9, 2026
- 8-K reportNov 5, 2026
- 8-K reportNov 3, 2026
- PRESS-RELEASE reportOct 30, 2026
- 8-K reportOct 22, 2026
- 8-K reportOct 14, 2026
- 8-K reportOct 9, 2026
- 8-K reportOct 7, 2026
- 8-K reportSep 3, 2026
- 8-K reportSep 3, 2026
- 8-K reportAug 17, 2026
- 8-K reportAug 17, 2026
- 8-K reportJul 24, 2026
- 8-K reportJul 15, 2026
- 8-K reportMay 14, 2026
- S-3 reportMay 12, 2026
- 8-K reportApr 16, 2026
- 8-K reportApr 14, 2026
- PRESS-RELEASE reportApr 1, 2026
- 8-K reportMar 5, 2026
- PRESS-RELEASE reportMar 5, 2026